In the present study, we aimed to examine the KTN1 variants as a genetic risk factor for PD, the roles of the KTN1 variants in regulating mRNA expression in the putamen and SNc and putamen GMV, and whether KTN1 mRNA may be differentially expressed in the putamen and SNc between PD and controls. The gene discussed is KTN1; the disease is Parkinson disease.